| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon
|
Latagliata, R.
|
|
|
17 |
2 |
p. 281-285
|
artikel
|
| 2 |
Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy
|
Bogaerts, J.
|
|
|
17 |
2 |
p. 352-353
|
artikel
|
| 3 |
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
|
Ma, C.X.
|
|
|
17 |
2 |
p. 226-231
|
artikel
|
| 4 |
A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense™, G3139) and irinotecan in patients with metastatic colorectal cancer
|
Mita, M.M.
|
|
|
17 |
2 |
p. 313-321
|
artikel
|
| 5 |
A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer
|
Twelves, C.
|
|
|
17 |
2 |
p. 239-245
|
artikel
|
| 6 |
A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial
|
O'Brien, M.E.R.
|
|
|
17 |
2 |
p. 270-275
|
artikel
|
| 7 |
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
|
De Paoli, A.
|
|
|
17 |
2 |
p. 246-251
|
artikel
|
| 8 |
Chemotherapy-induced amenorrhea in early breast cancer
|
Ferretti, G.
|
|
|
17 |
2 |
p. 352
|
artikel
|
| 9 |
Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma
|
Steel, J.L.
|
|
|
17 |
2 |
p. 304-312
|
artikel
|
| 10 |
Comment on ‘Jaw avascular bone necrosis associated with long-term use of biphosphonates’
|
Errante, D.
|
|
|
17 |
2 |
p. 350-352
|
artikel
|
| 11 |
Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2–3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer
|
Lønning, P.E.
|
|
|
17 |
2 |
p. 217-225
|
artikel
|
| 12 |
Consumption of sweet foods and breast cancer risk in Italy
|
Tavani, A.
|
|
|
17 |
2 |
p. 341-345
|
artikel
|
| 13 |
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
|
Karthaus, M.
|
|
|
17 |
2 |
p. 289-296
|
artikel
|
| 14 |
Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the ‘Observatory on Elderly Patients’
|
Freyer, G.
|
|
|
17 |
2 |
p. 211-216
|
artikel
|
| 15 |
Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer
|
Nolè, F.
|
|
|
17 |
2 |
p. 322-329
|
artikel
|
| 16 |
Effects of new smoking regulations in Italy
|
Gallus, S.
|
|
|
17 |
2 |
p. 346-347
|
artikel
|
| 17 |
Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
|
Vergote, I.
|
|
|
17 |
2 |
p. 200-204
|
artikel
|
| 18 |
Hypersensitivity reactions to oxaliplatin: experience in a single institute
|
Siu, S.W.K.
|
|
|
17 |
2 |
p. 259-261
|
artikel
|
| 19 |
in this issue
|
|
|
|
17 |
2 |
p. 181
|
artikel
|
| 20 |
Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
|
Oyan, B.
|
|
|
17 |
2 |
p. 349-350
|
artikel
|
| 21 |
Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy
|
Avilés, A.
|
|
|
17 |
2 |
p. 286-288
|
artikel
|
| 22 |
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects
|
Colleoni, M.
|
|
|
17 |
2 |
p. 232-238
|
artikel
|
| 23 |
Non-adherence to endocrine therapy for breast cancer
|
Partridge, A.H.
|
|
|
17 |
2 |
p. 183-184
|
artikel
|
| 24 |
On prejudice and facts and choices
|
Köhne, C.-H.
|
|
|
17 |
2 |
p. 185-187
|
artikel
|
| 25 |
Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer
|
Fallowfield, L.
|
|
|
17 |
2 |
p. 205-210
|
artikel
|
| 26 |
Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma
|
Ogawa, Y.
|
|
|
17 |
2 |
p. 330-333
|
artikel
|
| 27 |
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study
|
Hotte, S.J.
|
|
|
17 |
2 |
p. 334-340
|
artikel
|
| 28 |
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
|
Nitti, D.
|
|
|
17 |
2 |
p. 262-269
|
artikel
|
| 29 |
Response to letter “Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy” by Bogaerts et al. (Ann Oncol 2006; 17: 352–353)
|
Cleator, S.
|
|
|
17 |
2 |
p. 353-354
|
artikel
|
| 30 |
Risk factors for venous thromboembolic events in cancer patients
|
Kröger, K.
|
|
|
17 |
2 |
p. 297-303
|
artikel
|
| 31 |
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention
|
Christodoulou, C.
|
|
|
17 |
2 |
p. 350
|
artikel
|
| 32 |
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil
|
Pfeiffer, P.
|
|
|
17 |
2 |
p. 252-258
|
artikel
|
| 33 |
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)
|
Krege, S.
|
|
|
17 |
2 |
p. 276-280
|
artikel
|
| 34 |
Table of Contents
|
|
|
|
17 |
2 |
p. ii-iii
|
artikel
|
| 35 |
The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review
|
Stefanidis, D.
|
|
|
17 |
2 |
p. 189-199
|
artikel
|
Tijdschrift beschrijving